ClinicalTrials.Veeva

Menu

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

R

Ronald Myers

Status

Enrolling

Conditions

Tobacco-Related Carcinoma
Lung Carcinoma

Treatments

Other: Counseling
Other: Educational Activity
Other: Survey Administration
Other: Electronic Health Record Review

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05679349
JT 24704 (Other Identifier)
22F.808
R01CA258849 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.

Full description

PRIMARY OBJECTIVES:

I. Assess intervention impact on lung cancer screening (LCS). II. Assess intervention impact on shared decision making (SDM).

SECONDARY OBJECTIVES:

I. Identify mediators and moderators of LCS. II. Assess intervention implementation barriers and facilitators.

EXPLORATORY OBJECTIVES:

I. Assess intervention impact on:

Ia. LCS referral; Ib. Tobacco treatment services referral; Ic. Repeat annual LCS among participants with a normal initial screening result; Id. Follow-up diagnostic evaluation for participants with an abnormal screening result.

OUTLINE: Providers are randomized to 1 of 2 groups. Patients are randomized to 1 of 2 groups.

PROVIDERS:

GROUP A: PROVIDER SUPPORT GROUP: Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.

GROUP B: PROVIDER CONTROL GROUP: Participants complete survey at baseline and end of study survey.

PATIENTS:

GROUP A: Patients undergo electronic health records (EHR) review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.

GROUP B: Patients undergo EHR review on study and complete telephone survey throughout the trial.

Enrollment

822 estimated patients

Sex

All

Ages

50 to 77 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • PRACTICE LEVEL:
  • Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
  • Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
  • Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
  • PATIENT LEVEL:
  • Have an office or telemedicine established patient visit scheduled with a primary care provider in one of the participating practices within next 14 to 25 days
  • 50 to 77 years of age
  • Have at least a 20-pack-year smoking history (based on self-report at baseline eligibility assessment)
  • Currently smoke or have quit smoking within the past 15 years (based on self-report at baseline eligibility assessment)
  • Able to communicate in English or Spanish (determined at baseline eligibility assessment)

Exclusion criteria

  • PATIENT OUTREACH:

  • Any lung computed tomography (CT) or low-dose computed tomography (LDCT) scan in the past 11 months, current procedural terminology (CPT) Codes are as follows

    • G0297 - LDCT screening
    • 71250 - CT w/o contrast
    • 71260 - CT w/ contrast
    • 71270 - CT with and w/o contrast
    • 71275 - CT angiography chest
    • 78815 - Positron emission tomography computed tomography (PET CT) skull base to mid-thigh
    • 78816 - PET CT whole body
  • Prior history of lung cancer (The patient's problem list includes a problem with an international classification of diseases (ICD10) code of "Z85.118" or one beginning with "C34.", or by self-report at baseline eligibility assessment)

  • Recent hospitalization (Admission date within the last 60 days listed in electronic health record (EHR), or by self-report at baseline eligibility assessment)

  • Dementia (diagnosis codes F03.90 or F03.91) in EHR

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Quadruple Blind

822 participants in 4 patient groups

Group A (Providers): (survey, online educational activity)
Experimental group
Description:
Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
Treatment:
Other: Survey Administration
Other: Educational Activity
Other: Educational Activity
Other: Survey Administration
Other: Survey Administration
Group B (Providers): (survey)
Active Comparator group
Description:
Participants complete survey at baseline and end of study survey.
Treatment:
Other: Survey Administration
Other: Survey Administration
Other: Survey Administration
Group A (Patients): (EHR, educational activity, counseling))
Experimental group
Description:
Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
Treatment:
Other: Electronic Health Record Review
Other: Educational Activity
Other: Educational Activity
Other: Counseling
Other: Electronic Health Record Review
Group B (Patients): (survey)
Active Comparator group
Description:
Patients undergo EHR review on study and complete telephone survey throughout the trial.
Treatment:
Other: Electronic Health Record Review
Other: Survey Administration
Other: Survey Administration
Other: Electronic Health Record Review
Other: Survey Administration

Trial contacts and locations

1

Loading...

Central trial contact

Ronald Myers, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems